Organism and Cell Longevity: The Magical World Of Mushrooms

By Ria Pande

An Introduction to Magic Mushrooms

Magic mushrooms, containing the naturally occurring compound psilocybin, have been an area of intrigue for much of human history, often causing a multitude of polarizing opinions depending on who you ask and where you look. These psychedelic mushrooms are known to bring about hallucinations, altered states of reality, intense emotions, synesthesia, and spiritual experiences, while also having a large variety of therapeutic benefits. Currently, psilocybin is in Phase 2 and 3 clinical trials for potential treatment of Major Depressive Disorder and Treatment-Resistant Depression, with expedited FDA review after President Trump’s executive order of April 2026. 

Recent studies have been expanding the scope of what psilocybin may be useful for, leading to a groundbreaking 2025 study from Baylor College of Medicine regarding the use of psilocybin for potentially slowing down aging. This study, titled “Psilocybin treatment extends cellular lifespan and improves survival of aged mice,” displays how administration of psilocybin in mice, equivalent in age to 60-year-old humans, increased their lifespans and even noticeably improved their fur quality. This same study found that psilocybin administration was also able to extend cellular lifespan by up to 57% in human cells. 

Despite all these proven therapeutic benefits and recent scientific advances indicating new potential advantages, psilocybin is currently federally illegal in the U.S. through the Controlled Substances Act of 1970, with only some regions decriminalizing its possession within the past 7 years, but recent scientific advances could lead a shift towards greater public acceptance of psilocybin.

Psilocybin Administration for Therapy and Longevity

There has been a great deal of scientific progress in regards to psilocybin in recent years. Within human studies, psilocybin has had proven therapeutic benefits for treating a wide variety of conditions including depression, anxiety, PTSD, cancer-related psychiatric distress, cluster headaches, OCD, and, interestingly given the historical background, addiction. 

Through the previously mentioned 2025 study from Baylor College of Medicine, we now know psilocybin has the additional ability to increase the lifespan of aged mice. Remarkably, researchers found that psilocybin administration extended cellular lifespan up to 57% within human fibroblasts. This study analyzed specifically skin and lung fibroblasts, but fibroblasts are also found throughout the human body and major organs. Seeing that the same pathways in model organisms also lead to extended cellular lifespans within human cells gives a positive indication towards psilocybin’s use for improving human longevity as well.

Benefits in humans and model organisms include:

• Reduced oxidative stress
• Increased neuroprotection
• Increased DNA repair 
• Preserved telomere length
• Delayed cellular senescence
• Improved cellular longevity

Benefits currently proven in model organisms include:

• Phenotypic improvement of aging symptoms such as…
  • Improved fur quality 
  • Increased hair growth
  • Reduction in white hair
• Increased lifespans

Oxidative stress: An imbalance where there is an accumulation of unstable free radicals in relation to antioxidant defenses in the body. Reducing oxidative stress levels reduces inflammation, prevents disease, causes increased energy, minimizes wrinkles, and improves cognitive function through protection of healthy DNA, mitochondria, cells, and tissues. 

Cellular senescence: The process of cell-cycle arrest when a damaged cell stops dividing but remains metabolically active. This process is beneficial for processes like cancer prevention and wound healing in young tissues, but as senescent cells continue to linger, they secrete a toxic mix of inflammatory molecules, growth factors, and enzymes. This toxic combination is called the Senescence-Associated Secretory Phenotype (SASP), which ends up degrading surrounding tissues and forcing healthy neighboring cells into senescence as well. Think of these senescent cells as though they are zombie cells still hanging around, and as their number increases, they have a stronger ability to attack healthy cells. Cellular senescence being delayed through psilocybin administration and psilocybin working to fight back against the zombies allows for tissue to have a reduced potential of secreting SASP, reducing the damaging effects on tissues that result from accumulation through aging. 

Telomere degradation: Classic indication of aging. Telomeres are protective caps of repetitive DNA found at the ends of chromosomes, similar to how aglets, or ends of shoelaces, function as a protective covering to prevent the fibers from unraveling. As telomeres, which are protective caps of repetitive DNA found at the ends of chromosomes, shorten as we age, oxidative stress and senescence accumulates, leading to inflammation, disease, and aging, demonstrating how telomere protection is a vital solution to increasing cellular longevity. 

Adverse Side Effects

Psilocybin is not addictive, does not cause physical dependence, or daily cravings and has an extremely low risk of a fatal overdose.  However, some of the reported side effects of psilocybin include hallucinations, nausea, increased blood pressure and heart rate, dizziness, fatigue, poor sleep, paranoia, and altered perception of reality. People can experience extreme fear, confusion, or panic, and people who microdose mushrooms may experience symptoms of “insomnia, anxiety and depression, poor mood, low energy, physical discomfort, poor focus and cognitive functioning, and impaired social skills.”[1] Psilocybin is not safe for people with schizophrenia or severe forms of bipolar disorder and borderline personality disorder. At very high doses, psilocybin can cause death, and some poisonous mushrooms may look very similar to psilocybin-containing mushrooms, which brings up another area of caution.

Into the Future 

Psilocybin already has varying decriminalization laws regarding personal possession, religious usage, and usage under the care of a trained therapist depending on the region. The recent expedited FDA review process indicates that psilocybin may become more available in upcoming years, having the potential to alter its placement in current legislation. Especially with the current federally illegal status of psilocybin and the rise of new research, it’s important to give time for full clinical trials to be conducted on people with the intention of increasing longevity and improving aging symptoms before utilizing psilocybin for these purposes. With all of this information, we can see the widening scope of psilocybin’s benefits and a new unique perspective of increasing our longevity and improving our journeys of aging.